Free Trial
OTCMKTS:FSDDF

FSD Pharma (FSDDF) Stock Price, News & Analysis

$9.08 +0.34 (+3.83%)
As of 05/9/2025

About FSD Pharma Stock (OTCMKTS:FSDDF)

Key Stats

Today's Range
$8.60
$9.45
50-Day Range
$4.22
$9.18
52-Week Range
$3.43
$68.66
Volume
189,259 shs
Average Volume
11,100 shs
Market Capitalization
$68.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

FSD Pharma, Inc. is a specialty biotech pharmaceutical research and development company. It focuses on developing over time a robust pipeline of FDA-approved synthetic compounds targeting the endocannabinoid system of the human body to treat certain diseases of the central nervous system and autoimmune disorders of the skin, GI tract, and the musculoskeletal system. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz in 1994 and is headquartered in Cobourg, Canada.

Receive FSDDF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FSD Pharma and its competitors with MarketBeat's FREE daily newsletter.

FSDDF Stock News Headlines

QNTM Quantum BioPharma Ltd.
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
FSD Pharma Inc. (HUGE)
See More Headlines

FSDDF Stock Analysis - Frequently Asked Questions

FSD Pharma's stock was trading at $3.68 on January 1st, 2025. Since then, FSDDF shares have increased by 146.6% and is now trading at $9.0750.
View the best growth stocks for 2025 here
.

Shares of FSDDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Agricultural Commodities & Milling
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:FSDDF
CIK
N/A
Web
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$70,000.00
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$68.79 million
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (OTCMKTS:FSDDF) was last updated on 5/13/2025 by MarketBeat.com Staff
From Our Partners